Delirium. Delirium, unspecified
Conditions
Interventions
Intervention 1: 40 patients who had delirium treated with atorvastatin (40 mg/day). Intervention 2: In control group 50 patients who had delirium received placebo.
Treatment - Drugs
Placebo
40 patients who had delirium treated with atorvastatin (40 mg/day).
In control group 50 patients who had delirium received placebo.
Sponsors
Shahid Sadoughi University of Medical Sciences
Eligibility
Sex/Gender
All
Age
31 Years to 84 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Conscious patients and Exclusion criteria: Suffering from any known psychological disorder? hepatic dysfunctions? renal dysfunctions? treated with macrolide drugs
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CRP. Timepoint: before intervention and after intervention. Method of measurement: milligram per Liiter.;Richmond agitation-sedation score. Timepoint: BID. Method of measurement: standard Richmond sheet.;APACHE II score. Timepoint: Once a day. Method of measurement: standard APACHE II sheet. | — |
Secondary
| Measure | Time frame |
|---|---|
| GCS. Timepoint: BID. Method of measurement: degree.;Ventilated. Timepoint: after intervention. Method of measurement: day. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Seyed Mojtaba Sohrevardi
Faculty of Pharmacy- Shahid Sadoughi University of Medical Sciences
Outcome results
None listed